Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine or esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial

This publication has 46 references indexed in Scilit:

• What Did STAR*D Teach Us? Results From a Large-Scale, Practical, Clinical Trial for Patients With Depression
  Psychiatric Services, 2009
• Measurement-based care for refractory depression: A clinical decision support model for clinical research and practice
  Drug and Alcohol Dependence, 2007
• Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
  American Journal of Psychiatry, 2006
• A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Major Depression
  Archives of General Psychiatry, 2006
• Algorithms and Collaborative-care Systems for Depression: Are They Effective and Why?
  Biological Psychiatry, 2006
• Relationship Between Dopamine D₂ Occupancy, Clinical Response, and Side Effects: A Double-Blind PET Study of First-Episode Schizophrenia
  American Journal of Psychiatry, 2000
• Measurement of dissociative states with the Clinician‐Administered Dissociative States Scale (CADSS)
  Journal of Traumatic Stress, 1998
• DEFINITION AND EPIDEMIOLOGY OF TREATMENT-RESISTANT DEPRESSION
  Psychiatric Clinics of North America, 1996
• A New Depression Scale Designed to be Sensitive to Change
  The British Journal of Psychiatry, 1979
• Relationship between Plasma Level and Therapeutic Effect of Nortriptyline
  BMJ, 1971